Given the excellent efficacy of SAC in inducing MM cell death in vitro, we assessed the effectiveness of SAC targeting METTL5 in an orthotopical xenograft model of MM established by injecting RPMI-8226-Luc cells (Supplementary Fig. 10A). Here, METTL5 is linked to Miyoshi myopathy.